The global behavioral health market size is calculated at USD 184.94 billion in 2025 and is forecasted to reach around USD 330.35 billion by 2034, accelerating at a CAGR of 6.70% from 2025 to 2034. The North America behavioral health market size surpassed USD 110.40 billion in 2024 and is expanding at a CAGR of 6.30% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Behavioral Health Industry Impact
5.2. Behavioral Health Business Impact Assessment: Covid-19
5.2.1. Market Trends and Behavioral Health Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Behavioral Health Manufacturers to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Behavioral Health Market Revenue by Manufacturer
7.1.1.2. Behavioral Health Market Revenue Market Share by Manufacturer
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Behavioral Health Market, by Services
8.1.1. Home-Based Treatment Services
8.1.1.1. Market Revenue and Forecast
8.1.2. Outpatient Counselling
8.1.2.1. Market Revenue and Forecast
8.1.3. Emergency Mental Health Services
8.1.3.1. Market Revenue and Forecast
8.1.4. Inpatient Hospital Treatment
8.1.4.1. Market Revenue and Forecast
8.1.5. Intensive Care Management
8.1.5.1. Market Revenue and Forecast
9.1. Behavioral Health Market, by Disorder
9.1.1. Bipolar Disorder
9.1.1.1. Market Revenue and Forecast
9.1.2. Anxiety Disorder
9.1.2.1. Market Revenue and Forecast
9.1.3. Depression
9.1.3.1. Market Revenue and Forecast
9.1.4. Post-Traumatic Stress Disorder
9.1.4.1. Market Revenue and Forecast
9.1.5. Eating Disorder
9.1.5.1. Market Revenue and Forecast
9.1.6. Substance Abuse Disorder
9.1.6.1. Market Revenue and Forecast
10.1. Behavioral Health Market, by End-User
10.1.1. Outpatient Clinics
10.1.1.1. Market Revenue and Forecast
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast
10.1.3. Rehabilitation Centers
10.1.3.1. Market Revenue and Forecast
10.1.4. Homecare Setting
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue Forecast by Product
11.1.2. Market Revenue by Disorder
11.1.3. Market Revenue Forecast by End-User
11.1.4. U.S
11.1.4.1. Market Revenue Forecast
11.1.5. Canada
11.1.5.1. Market Revenue Forecast
11.2. Europe
11.2.1. Market Revenue Forecast by Product
11.2.2. Market Revenue by Disorder
11.2.3. Market Revenue Forecast by End-User
11.2.4. UK
11.2.4.1. Market Revenue Forecast
11.2.4.2.
11.2.5. Germany
11.2.5.1. Market Revenue Forecast
11.2.6. France
11.2.6.1. Market Revenue Forecast
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product
11.3.2. Market Revenue by Disorder
11.3.3. Market Revenue Forecast by End-User
11.3.4. China
11.3.4.1. Market Revenue Forecast
11.3.5. India
11.3.5.1. Market Revenue Forecast
11.3.6. Japan
11.3.6.1. Market Revenue Forecast
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast
11.4. LATAM
11.4.1. Market Revenue Forecast by Product
11.4.2. Market Revenue by Disorder
11.4.3. Market Revenue Forecast by End-User
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product
11.5.2. Market Revenue by Disorder
11.5.3. Market Revenue Forecast by End-User
11.5.4. GCC
11.5.4.1. Market Revenue Forecast
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast
12.1. Acadia Healthcare
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Disorder
12.1.3. Revenue, Production Capacity, Price and Gross Margin
12.1.4. Recent Developments and Strategies
12.2. CareTech Holdings plc
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Disorder
12.2.3. Revenue, Production Capacity, Price and Gross Margin
12.2.4. Recent Developments and Strategies
12.3. Elements Behavioral Health
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Disorder
12.3.3. Revenue, Production Capacity, Price and Gross Margin
12.3.4. Recent Developments and Strategies
12.4. Epic Health Services
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Disorder
12.4.3. Revenue, Production Capacity, Price and Gross Margin
12.4.4. Recent Developments and Strategies
12.5. Pyramid Healthcare
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Disorder
12.5.3. Revenue, Production Capacity, Price and Gross Margin
12.5.4. Recent Developments and Strategies
12.6. Universal Health Services
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Disorder
12.6.3. Revenue, Production Capacity, Price and Gross Margin
12.6.4. Recent Developments and Strategies
12.7. Company 7
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Disorder
12.7.3. Revenue, Production Capacity, Price and Gross Margin
12.7.4. Recent Developments and Strategies
12.8. Company 8
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Disorder
12.8.3. Revenue, Production Capacity, Price and Gross Margin
12.8.4. Recent Developments and Strategies
12.9. Company 9
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Disorder
12.9.3. Revenue, Production Capacity, Price and Gross Margin
12.9.4. Recent Developments and Strategies
12.10. Company 10
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Disorder
12.10.3. Revenue, Production Capacity, Price and Gross Margin
12.10.4. Recent Developments and Strategies
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample